Related Experiment Video
Updated: Jul 19, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Pneumococcal vaccination: expected benefits in adults].
1CNAM-Chaire hygiène et sécurité, 2, rue Conte, 75141 Paris cedex 03, France. laura.temime@cnam.fr
La Revue De Medecine Interne
|October 3, 2006
Summary
Pneumococcal vaccines prevent serious infections like pneumonia and meningitis. Optimal use of polysaccharide and conjugate vaccines is crucial, especially with rising antibiotic resistance, to protect all age groups.
Area of Science:
- Bacteriology
- Immunology
- Vaccinology
Context:
- Streptococcus pneumoniae causes pneumonia, meningitis, and otitis media globally.
- Polysaccharide vaccines have a 50-year history; conjugate vaccines offer immunological memory but limited serotype coverage.
- Vaccine efficacy and serotype coverage vary across age groups and health statuses.
Purpose:
- To evaluate the benefits of pneumococcal vaccination in the context of antibiotic resistance.
- To inform optimal vaccination strategies for diverse populations.
- To address the limitations of current pneumococcal vaccines.
Summary:
- Polysaccharide vaccines are effective against invasive pneumococcal disease (IPD) in adults, but efficacy against pneumonia and in specific populations is debated.
- Conjugate vaccines significantly reduce IPD incidence and colonization in children via herd immunity, yet adult serotype coverage is low, posing long-term replacement risks.
- Assessing vaccination benefits is critical for strategic deployment against evolving pneumococcal threats.
Impact:
- Informs public health policy on pneumococcal vaccination.
- Guides the development of broader-coverage pneumococcal vaccines.
- Contributes to strategies for combating antibiotic-resistant bacterial infections.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:51Vaccinations
Overview
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...